Cargando…
Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay
The neurodegenerative Huntington’s disease (HD) is caused by a polyglutamine (polyQ) amplification in the huntingtin protein (HTT). Currently there is no effective therapy available for HD; however, several efforts are directed to develop and optimize HTT-lowering methods to improve HD phenotypes. T...
Autores principales: | Baldo, Barbara, Sajjad, Muhammad Umar, Cheong, Rachel Y., Bigarreau, Julie, Vijayvargia, Ravi, McLean, Catriona, Perrier, Anselme L., Seong, Ihn Sik, Halliday, Glenda, Petersén, Åsa, Kirik, Deniz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179573/ https://www.ncbi.nlm.nih.gov/pubmed/30310861 http://dx.doi.org/10.1523/ENEURO.0234-18.2018 |
Ejemplares similares
-
Comparison of AlphaLISA and RIA assays for measurement of wool cortisol concentrations
por: Peric, T., et al.
Publicado: (2020) -
Development of an AlphaLISA assay for sensitive and accurate detection of influenza B virus
por: Zong, Huijun, et al.
Publicado: (2023) -
Effects of mutant huntingtin inactivation on Huntington disease‐related behaviours in the BACHD mouse model
por: Cheong, Rachel Y., et al.
Publicado: (2021) -
Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA
por: Tak For Yu, Zeta, et al.
Publicado: (2015) -
Rapid and sensitive detection of botulinum toxin type A in complex sample matrices by AlphaLISA
por: Zhang, Liwen, et al.
Publicado: (2022)